United States

Top 538 largest US Companies in the Biotechnology industry by Market Cap

This is the list of the largest public listed companies in the Biotechnology industry from the United States by market capitalization with links to their reference stock.

United States Biotechnology Industry Analysis
Top US Companies United States Analysis
World Top Companies World Companies Analysis

Top 1-year algo backtest: +327.04%

$10,000 in March 2024 would now be $42,704 by following this algorithm daily at market close.

Use AI to boost your investing & swing trading, now!

Try Disfold DeepFinance FREE

Top Biotechnology Companies from the United States as of Jan. 01, 2025

Download Excel

Rank Company Market Cap (USD) Country Sector Industry
181 Chimerix, Inc. $356.3 M United States US Healthcare US Biotechnology
182 Compass Therapeutics, Inc. $344.0 M United States US Healthcare US Biotechnology
183 Cerus Corporation $343.6 M United States US Healthcare US Biotechnology
184 Silverback Therapeutics, Inc. $341.8 M

(July 1, 2024)

 United States US Healthcare US Biotechnology
185 Corvus Pharmaceuticals, Inc. $339.3 M United States US Healthcare US Biotechnology
186 Lexicon Pharmaceuticals, Inc. $320.0 M United States US Healthcare US Biotechnology
187 Taysha Gene Therapies, Inc. $313.6 M United States US Healthcare US Biotechnology
188 Voyager Therapeutics, Inc. $307.0 M United States US Healthcare US Biotechnology
189 XOMA Corporation $306.5 M United States US Healthcare US Biotechnology
190 Aldeyra Therapeutics, Inc. $304.9 M United States US Healthcare US Biotechnology
191 Oyster Point Pharma, Inc. $299.9 M

(Dec. 1, 2022)

 United States US Healthcare US Biotechnology
192 iTeos Therapeutics, Inc. $292.3 M United States US Healthcare US Biotechnology
193 Atea Pharmaceuticals, Inc. $285.1 M United States US Healthcare US Biotechnology
194 Cerecor Inc. $285.0 M

(June 1, 2022)

 United States US Healthcare US Biotechnology
195 Aquestive Therapeutics, Inc. $281.7 M United States US Healthcare US Biotechnology
196 Y-mAbs Therapeutics, Inc. $281.3 M United States US Healthcare US Biotechnology
197 Eledon Pharmaceuticals, Inc. $278.4 M United States US Healthcare US Biotechnology
198 C4 Therapeutics, Inc. $273.9 M United States US Healthcare US Biotechnology
199 CytoDyn, Inc. $270.2 M United States US Healthcare US Biotechnology
200 DiaMedica Therapeutics Inc. $269.4 M United States US Healthcare US Biotechnology
201 Aclaris Therapeutics, Inc. $268.6 M United States US Healthcare US Biotechnology
202 Heron Therapeutics, Inc. $267.7 M United States US Healthcare US Biotechnology
203 Verastem, Inc. $263.5 M United States US Healthcare US Biotechnology
204 Vanda Pharmaceuticals Inc. $257.7 M United States US Healthcare US Biotechnology
205 Chiasma, Inc. $253.0 M

(July 1, 2021)

 United States US Healthcare US Biotechnology
206 Epizyme, Inc. $247.5 M

(Aug. 1, 2022)

 United States US Healthcare US Biotechnology
207 BioStem Technologies, Inc. $247.3 M United States US Healthcare US Biotechnology
208 Sangamo Therapeutics, Inc. $242.0 M United States US Healthcare US Biotechnology
209 Anika Therapeutics, Inc. $239.7 M United States US Healthcare US Biotechnology
210 Foghorn Therapeutics Inc. $236.8 M United States US Healthcare US Biotechnology

Top Biotechnology Companies from the United States as of Jan. 01, 2025

181. Chimerix, Inc.

Company Profile: Chimerix, Inc.
Market Cap (USD): $356.3 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

182. Compass Therapeutics, Inc.

Company Profile: Compass Therapeutics, Inc.
Market Cap (USD): $344.0 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

183. Cerus Corporation

Company Profile: Cerus Corporation
Market Cap (USD): $343.6 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

184. Silverback Therapeutics, Inc.

Company Profile: Silverback Therapeutics, Inc.
Market Cap (USD): $341.8 M (July 1, 2024)
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

185. Corvus Pharmaceuticals, Inc.

Company Profile: Corvus Pharmaceuticals, Inc.
Market Cap (USD): $339.3 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

186. Lexicon Pharmaceuticals, Inc.

Company Profile: Lexicon Pharmaceuticals, Inc.
Market Cap (USD): $320.0 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

187. Taysha Gene Therapies, Inc.

Company Profile: Taysha Gene Therapies, Inc.
Market Cap (USD): $313.6 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

188. Voyager Therapeutics, Inc.

Company Profile: Voyager Therapeutics, Inc.
Market Cap (USD): $307.0 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

189. XOMA Corporation

Company Profile: XOMA Corporation
Market Cap (USD): $306.5 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

190. Aldeyra Therapeutics, Inc.

Company Profile: Aldeyra Therapeutics, Inc.
Market Cap (USD): $304.9 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

191. Oyster Point Pharma, Inc.

Company Profile: Oyster Point Pharma, Inc.
Market Cap (USD): $299.9 M (Dec. 1, 2022)
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

192. iTeos Therapeutics, Inc.

Company Profile: iTeos Therapeutics, Inc.
Market Cap (USD): $292.3 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

193. Atea Pharmaceuticals, Inc.

Company Profile: Atea Pharmaceuticals, Inc.
Market Cap (USD): $285.1 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

194. Cerecor Inc.

Company Profile: Cerecor Inc.
Market Cap (USD): $285.0 M (June 1, 2022)
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

195. Aquestive Therapeutics, Inc.

Company Profile: Aquestive Therapeutics, Inc.
Market Cap (USD): $281.7 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

196. Y-mAbs Therapeutics, Inc.

Company Profile: Y-mAbs Therapeutics, Inc.
Market Cap (USD): $281.3 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

197. Eledon Pharmaceuticals, Inc.

Company Profile: Eledon Pharmaceuticals, Inc.
Market Cap (USD): $278.4 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

198. C4 Therapeutics, Inc.

Company Profile: C4 Therapeutics, Inc.
Market Cap (USD): $273.9 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

199. CytoDyn, Inc.

Company Profile: CytoDyn, Inc.
Market Cap (USD): $270.2 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

200. DiaMedica Therapeutics Inc.

Company Profile: DiaMedica Therapeutics Inc.
Market Cap (USD): $269.4 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

201. Aclaris Therapeutics, Inc.

Company Profile: Aclaris Therapeutics, Inc.
Market Cap (USD): $268.6 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

202. Heron Therapeutics, Inc.

Company Profile: Heron Therapeutics, Inc.
Market Cap (USD): $267.7 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

203. Verastem, Inc.

Company Profile: Verastem, Inc.
Market Cap (USD): $263.5 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

204. Vanda Pharmaceuticals Inc.

Company Profile: Vanda Pharmaceuticals Inc.
Market Cap (USD): $257.7 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

205. Chiasma, Inc.

Company Profile: Chiasma, Inc.
Market Cap (USD): $253.0 M (July 1, 2021)
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

206. Epizyme, Inc.

Company Profile: Epizyme, Inc.
Market Cap (USD): $247.5 M (Aug. 1, 2022)
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

207. BioStem Technologies, Inc.

Company Profile: BioStem Technologies, Inc.
Market Cap (USD): $247.3 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

208. Sangamo Therapeutics, Inc.

Company Profile: Sangamo Therapeutics, Inc.
Market Cap (USD): $242.0 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

209. Anika Therapeutics, Inc.

Company Profile: Anika Therapeutics, Inc.
Market Cap (USD): $239.7 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

210. Foghorn Therapeutics Inc.

Company Profile: Foghorn Therapeutics Inc.
Market Cap (USD): $236.8 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

Top 1-year algo backtest: +327.04% - Try Disfold DeepFinance for FREE now!

Stay in touch